Zynerba Pharmaceuticals, Inc. (ZYNE)
NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
收市價： 04:00PM EST
收市後：
| 前收市價 | 0.6106 |
| 開市 | 0.6400 |
| 買盤 | 0.6301 x 1200 |
| 賣出價 | 0.6288 x 1100 |
| 今日波幅 | 0.6011 - 0.6400 |
| 52 週波幅 | 0.4900 - 2.9400 |
| 成交量 | |
| 平均成交量 | 325,747 |
| 市值 | 29.659M |
| Beta 值 (5 年，每月) | 1.66 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.9620 |
| 業績公佈日 | 2023年2月27日 - 2023年3月03日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 5.44 |
- Benzinga
Zynerba's Cannabidiol Formulated Gel Shows Encouraging Action In Genetic Disease
Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) announced positive top-line results from the Phase 2 INSPIRE trial of Zygel (Transdermal CBD gel) on pediatric behavioral and emotional symptoms of 22q11.2 deletion syndrome. The total score and all five subscales of the Anxiety, Depression, and Mood Scale showed statistically significant improvements at 14 weeks of treatment compared to baseline. All five subscales of the Aberrant Behavior Checklist – Community showed statistically significant improvem
